Remicade (Infliximab)

The trade name of Infliximab is Remicade. This biologic drug is used for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis and also used off-label outside its FDA approval for Behcet's disease and other conditions. Remicade is the first approved TNF-alpha inhibitor available in the U.S.  Remicade infusion therapy is used to treat Crohn's disease, ulcerative colitis, and rheumatoid arthritis. Stomach...

Continue reading

Rituxan 500 mg

Rituxan, A Type of Antibody Therapy

Rituximab with the trade name Rituxan is an oncology drug that interferes with the growth and spread of cancer cells in the body. Rituxan infusion(a CD20-directed cytolytic antibody) is used to treat certain autoimmune diseases and types of cancer. This type of antibody therapy can be used alone or with chemotherapy. This drug is on the World Health Organization's List...

Continue reading

Avastin 400 mg

Avastin, An Angiogenesis Inhibitor

Bevacizumab with the trade name Avastin was the first available angiogenesis inhibitor in the United States. It is a “monoclonal antibody” and “anti-angiogenesis” drug used to treat a number of types of cancers by interfering with the growth and spread of cancer cells in the body and it is also used for specific eye diseases.

Continue reading